# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-22-015973
Filing Date
2022-04-26
Accepted
2022-04-26 16:42:35
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | ny20003107x2_defa14a.htm | DEFA14A | 8087
2 |  | ny20003107x2_nc01.jpg | GRAPHIC | 957282
3 |  | ny20003107x2_nc02.jpg | GRAPHIC | 562934
| Complete submission text file | 0001140361-22-015973.txt |  | 2103113

Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

EIN.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36579 | Film No.: 22854953
SIC: 2836 Biological Products, (No Diagnostic Substances)